Photocure ASA logo

PHO - Photocure ASA Share Price

NOK125.5 1.1  0.9%

Last Trade - 14/05/21

Small Cap
Market Cap £286.9m
Enterprise Value £262.5m
Revenue £22.0m
Position in Universe 620th / 1828
Unlock PHO Revenue
Relative Strength (%)
1m -5.38%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
134.7 143.6 150.9 181.5 281.6 256.5 382.5 508.5 +13.7%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Photocure ASA revenues decreased 9% to NOK256.5M. Net losstotaled NOK22.4M vs. income of NOK31.8M. Revenues reflectSigning fees and milestone revenues decrease from NOK67.6Mto NOK0K. Net loss reflects Marketing and sales expensesincrease of 26% to NOK187.8M (expense), Financial Expenses- Balancing value increase from NOK499K to NOK23.4M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


PHO Revenue Unlock PHO Revenue

Net Income

PHO Net Income Unlock PHO Revenue

Normalised EPS

PHO Normalised EPS Unlock PHO Revenue

PE Ratio Range

PHO PE Ratio Range Unlock PHO Revenue

Dividend Yield Range

PHO Dividend Yield Range Unlock PHO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PHO EPS Forecasts Unlock PHO Revenue
Profile Summary

Photocure ASA is a Norway-based company active in the pharmaceutical industry. It operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The Company is a parent of a wholly owned entity, Photocure Inc.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 20, 1995
Public Since May 29, 2000
No. of Shareholders: n/a
No. of Employees: 67
Sector Healthcare
Industry Pharmaceuticals
Exchange Oslo Stock Exchange
Shares in Issue 26,701,870
Free Float (0.0%)
Eligible for
PHO Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PHO
Upcoming Events for PHO
Wednesday 19th May, 2021
Q1 2021 Photocure ASA Earnings Release
Wednesday 19th May, 2021
Q1 2021 Photocure ASA Earnings Presentation
Thursday 20th May, 2021
Photocure ASA Annual Shareholders Meeting
Frequently Asked Questions for Photocure ASA
What is the Photocure ASA share price?

As of 14/05/21, shares in Photocure ASA are trading at NOK125.5, giving the company a market capitalisation of £286.9m. This share price information is delayed by 15 minutes.

How has the Photocure ASA share price performed this year?

Shares in Photocure ASA are currently trading at NOK125.5 and the price has moved by 76.76% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Photocure ASA price has moved by 38.46% over the past year.

What are the analyst and broker recommendations for Photocure ASA?

Of the analysts with advisory recommendations for Photocure ASA, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Photocure ASA is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Photocure ASA next release its financial results?

Photocure ASA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Photocure ASA dividend yield?

Photocure ASA does not currently pay a dividend.

Does Photocure ASA pay a dividend?

Photocure ASA does not currently pay a dividend.

When does Photocure ASA next pay dividends?

Photocure ASA does not currently pay a dividend.

How do I buy Photocure ASA shares?

To buy shares in Photocure ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Photocure ASA?

Shares in Photocure ASA are currently trading at NOK125.5, giving the company a market capitalisation of £286.9m.

Where are Photocure ASA shares listed? Where are Photocure ASA shares listed?

Here are the trading details for Photocure ASA:

Country of listing: Norway
Exchange: OSL
Ticker Symbol: PHO
What kind of share is Photocure ASA?

Based on an overall assessment of its quality, value and momentum, Photocure ASA is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Photocure ASA share price forecast 2021?

Shares in Photocure ASA are currently priced at NOK125.5. At that level they are trading at 27.49% discount to the analyst consensus target price of 0.00.

Analysts covering Photocure ASA currently have a consensus Earnings Per Share (EPS) forecast of 0.075 for the next financial year.

How can I tell whether the Photocure ASA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Photocure ASA. Over the past six months, the relative strength of its shares against the market has been 34.44%. At the current price of NOK125.5, shares in Photocure ASA are trading at 23.72% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Photocure ASA PE Ratio?

We were not able to find PE ratio data for Photocure ASA.

Who are the key directors of Photocure ASA?

Photocure ASA's management team is headed by:

Grete Hogstad - VPR
Inger Ferner Heglund - VRD
Gry Stensrud - VOP
Ambaw Bellete - CEX
Erik Dahl - CFO
Espen Njastein - OTH
Grannum Sant - DRC
Johanna Holldack - DRC
Gwen Mellincoff - DRC
Jan Egberts - CHM
Jeremy Bahr - OTH
Daniel Schneider - PRE
Einar Antonsen - DRC
Tove Ringvold - DRC
Susanne Strauss - VPR
Who are the major shareholders of Photocure ASA?

Here are the top five shareholders of Photocure ASA based on the size of their shareholding:

Briarwood Chase Management LLC Hedge Fund
Percentage owned: 5.28% (1.42m shares)
DNB Asset Management AS Investment Advisor/Hedge Fund
Percentage owned: 5.16% (1.38m shares)
Coeli Asset Management Investment Advisor/Hedge Fund
Percentage owned: 2.82% (755k shares)
Percentage owned: 2.53% (680k shares)
KLP Forsikring Pension Fund
Percentage owned: 2.44% (655k shares)
Similar to PHO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.